Stockscreener 앱 받기
70.97
0.17%
0.12
시간 외 거래:
70.02
-0.95
-1.34%
전일 마감가:
$70.85
열려 있는:
$70.36
하루 거래량:
779.89K
Relative Volume:
1.04
시가총액:
$3.57B
수익:
$379.25M
순이익/손실:
$-77.34M
주가수익비율:
-44.02
EPS:
-1.6122
순현금흐름:
$-27.87M
1주 성능:
+0.65%
1개월 성능:
-2.71%
6개월 성능:
+62.44%
1년 성능:
+75.45%
1일 변동 폭
$69.75
$72.62
1주일 범위
$68.34
$73.23
52주 변동 폭
$36.88
$78.54
Mirum Pharmaceuticals Inc Stock (MIRM) Company Profile
명칭
Mirum Pharmaceuticals Inc
전화
650-667-4085
주소
989 EAST HILLSDALE BOULEVARD, SUITE 300, FOSTER CITY
MIRM을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MIRM
Mirum Pharmaceuticals Inc
|
70.97 | 3.56B | 379.25M | -77.34M | -27.87M | -1.6122 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.67 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
628.00 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.47 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
831.48 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.77 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Mirum Pharmaceuticals Inc Stock (MIRM) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-24 | 개시 | TD Cowen | Buy |
| 2025-08-11 | 재개 | Stifel | Buy |
| 2025-05-19 | 재개 | H.C. Wainwright | Buy |
| 2024-04-17 | 개시 | Stifel | Buy |
| 2023-12-18 | 재확인 | H.C. Wainwright | Buy |
| 2023-11-20 | 재개 | JP Morgan | Overweight |
| 2023-11-13 | 개시 | Morgan Stanley | Overweight |
| 2023-10-24 | 개시 | Cantor Fitzgerald | Overweight |
| 2023-10-17 | 재개 | Evercore ISI | Outperform |
| 2023-09-20 | 개시 | JMP Securities | Mkt Outperform |
| 2022-09-01 | 개시 | Citigroup | Buy |
| 2021-09-20 | 개시 | JP Morgan | Overweight |
| 2020-08-07 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2020-08-03 | 개시 | H.C. Wainwright | Buy |
| 2020-07-31 | 개시 | Piper Sandler | Overweight |
| 2020-06-25 | 개시 | Robert W. Baird | Outperform |
| 2019-08-12 | 개시 | Citigroup | Buy |
| 2019-08-12 | 개시 | Evercore ISI | Outperform |
| 2019-08-12 | 개시 | Guggenheim | Buy |
| 2019-08-12 | 개시 | ROTH Capital | Buy |
| 2019-08-12 | 개시 | Raymond James | Outperform |
모두보기
Mirum Pharmaceuticals Inc 주식(MIRM)의 최신 뉴스
Earnings call transcript: Mirum Pharmaceuticals reports Q3 2025 earnings beat - Investing.com
Mirum Pharmaceuticals Lifts Guidance After LIVMARLI Sales Surge - Finimize
Mirum Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Business Update - Yahoo Finance
Is Mirum Pharmaceuticals Inc. (08D) stock worth buying before Fed actionShort Setup & Accurate Technical Buy Alerts - newser.com
How currency fluctuations impact Mirum Pharmaceuticals Inc. stock2025 Risk Factors & AI Based Trade Execution Alerts - newser.com
How to build a custom watchlist for Mirum Pharmaceuticals Inc.2025 Valuation Update & Weekly High Return Opportunities - newser.com
Will Mirum Pharmaceuticals Inc. see short term momentumMarket Risk Analysis & Safe Entry Zone Tips - newser.com
Will Mirum Pharmaceuticals Inc. (08D) stock keep high P E multiplesQuarterly Performance Summary & Precise Entry and Exit Recommendations - newser.com
Mirum Pharmaceuticals to Participate in Upcoming November 2025 Investor Conferences - BioSpace
Mirum Pharmaceuticals to Participate in Upcoming Investor Conferences - Yahoo Finance
Why analysts remain bullish on Mirum Pharmaceuticals Inc. stockAnalyst Upgrade & Smart Allocation Stock Tips - newser.com
Why Mirum Pharmaceuticals Inc. stock remains undervaluedBuy Signal & Weekly Breakout Opportunity Watchlist - newser.com
Will breakout in Mirum Pharmaceuticals Inc. lead to full recoveryJuly 2025 Final Week & Expert Approved Trade Ideas - newser.com
Is it time to cut losses on Mirum Pharmaceuticals Inc.Weekly Volume Report & High Yield Equity Trading Tips - newser.com
Is Mirum Pharmaceuticals Inc. stock supported by strong cash flowsSwing Trade & Daily Stock Momentum Reports - newser.com
Is Mirum Pharmaceuticals Inc. stock overvalued by current metricsWatch List & Real-Time Volume Trigger Notifications - newser.com
Mirum Pharmaceuticals Inc expected to post a loss of 16 cents a shareEarnings Preview - TradingView
Investors Aren't Buying Mirum Pharmaceuticals, Inc.'s (NASDAQ:MIRM) Revenues - 富途牛牛
What analysts say about Mirum Pharmaceuticals Inc stockMarket Profile Overview & High Return Trading Tips - earlytimes.in
Emerald Mutual Fund Advisers Trust Takes $11.07 Million Position in Mirum Pharmaceuticals, Inc. $MIRM - MarketBeat
How to use Fibonacci retracement on Mirum Pharmaceuticals Inc.July 2025 Selloffs & AI Driven Price Predictions - newser.com
Published on: 2025-10-31 03:46:47 - newser.com
Using RSI to spot recovery in Mirum Pharmaceuticals Inc.July 2025 Analyst Calls & Fast Entry High Yield Tips - newser.com
Published on: 2025-10-31 01:07:37 - newser.com
Published on: 2025-10-30 23:29:10 - newser.com
Emerald Advisers LLC Acquires Shares of 305,766 Mirum Pharmaceuticals, Inc. $MIRM - MarketBeat
Mirum Pharmaceuticals Experiences Revision in Stock Evaluation Amid Strong Market Performance - Markets Mojo
AlphaQuest LLC Sells 12,797 Shares of Mirum Pharmaceuticals, Inc. $MIRM - MarketBeat
Published on: 2025-10-29 01:58:20 - newser.com
Published on: 2025-10-29 01:50:33 - newser.com
Mirum Pharmaceuticals to Announce Third Quarter 2025 Financial Results and Host Conference Call on November 4, 2025 - BioSpace
Published on: 2025-10-28 04:35:21 - newser.com
Published on: 2025-10-28 02:45:58 - newser.com
Published on: 2025-10-28 00:12:15 - newser.com
Mirum Pharmaceuticals Inc (MIRM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.45%
0.86%
자본화:
|
볼륨(24시간):